Fox Chase Cancer Center Medical Group Inc

Analysis

Fox Chase Cancer Center Medical Group Inc is a registered charity in United States, based in Philadelphia, PA. It received its IRS tax-exemption ruling in July 2013, 13 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a hospital or medical research organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Fox Chase Cancer Center Medical Group Inc reported income of $89.7m and spending of $93.6m, spending 104% of its income. Across the 5 years on record, from June 2019 to June 2023, income grew from $76.5m to $89.7m (+17%), an average of +4.1% a year. The sharpest change came in the year to June 2023, when income rose by 16%. Over the whole period it spent 102% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Fox Chase Cancer Center Medical Group Inc sits at the 95th percentile: it is larger than about 95% of them. Against every charity in United States with reported income it ranks in the 99th percentile, and in the 99th percentile within PA. Charities of a similar size with the same main cause include Childrens Research Institute ($89.7m), Advocates for a Healthy Community Inc ($89.7m) and Defiance Hospital Inc ($89.7m).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 0.8% and program service revenue 99% of the total. Compensation of current officers, directors and key employees was $2.1m (2.3% of expenses). Other salaries and wages came to $68.0m. At year end it held assets of $37.1m against liabilities of $29.3m, net assets of $7.8m. It reported 314 employees.